Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Other Non-Current Assets (2016 - 2025)

Capricor Therapeutics (CAPR) has 15 years of Other Non-Current Assets data on record, last reported at $488738.0 in Q3 2025.

  • For Q3 2025, Other Non-Current Assets rose 53.09% year-over-year to $488738.0; the TTM value through Sep 2025 reached $488738.0, up 53.09%, while the annual FY2024 figure was $221700.0, 17.33% down from the prior year.
  • Other Non-Current Assets reached $488738.0 in Q3 2025 per CAPR's latest filing, down from $508002.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $508002.0 in Q2 2025 and bottomed at $88701.0 in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $278899.5, with a median of $268172.0 recorded in 2022.
  • The widest YoY moves for Other Non-Current Assets: up 225.48% in 2021, down 17.4% in 2021.
  • A 5-year view of Other Non-Current Assets shows it stood at $275722.0 in 2021, then fell by 2.74% to $268172.0 in 2022, then changed by 0.0% to $268172.0 in 2023, then fell by 17.33% to $221700.0 in 2024, then skyrocketed by 120.45% to $488738.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $488738.0 in Q3 2025, $508002.0 in Q2 2025, and $253374.0 in Q1 2025.